Chemoprevention of neuroblastoma: progress and promise beyond uncertainties

Abstract

Neuroblastoma is the most common extracranial solid tumor in children and comprises one-tenth of all childhood cancer deaths. The current clinical therapy for this deadly disease is multimodal, involving an induction phase with alternating regimens of high-dose chemotherapeutic drugs and load reduction surgery; a consolidation phase with more intensive chemotherapy, radiotherapy, and stem cell transplant; and a maintenance phase with immunotherapy and immune-activating cytokine treatment. Despite such intensive treatment, children with neuroblastoma have unacceptable life quality and survival, warranting preventive measures to regulate the cellular functions that orchestrate tumor progression, therapy resistance, metastasis, and tumor relapse/recurrence. Globally, active efforts are underway to identify novel chemopreventive agents, define their mechanism(s) of action, and assess their clinical benefit. Some chemoprevention strategies (e.g., retinoids, difluoromethylornithine) have already been adopted clinically as part of maintenance phase therapy. Several agents are in the pipeline, while many others are in preclinical characterization. Here we review the classes of chemopreventive agents investigated for neuroblastoma, including cellular events targeted, mode(s) of action, and the level of development. Our review: (i) highlights the pressing need for new and improved chemopreventive strategies for progressive neuroblastoma; (ii) lists the emerging classes of chemopreventive agents for neuroblastoma; and (iii) recognizes the relevance of targeting dynamically evolving hallmark functions of tumor evolution (e.g., survival, differentiation, lineage transformation). With recent gains in the understanding of tumor evolution processes and preclinical and clinical efforts, it is our strong opinion that effective chemopreventive strategies for aggressive neuroblastoma are a near reality.

Keywords

Neuroblastoma / chemoprevention / secondary and tertiary chemopreventive / phytochemicals / retinoids / polyphenols / terpenes / DFMO / apoptosis

References

[1] Aravindan N,Somasundaram DB,Aravindan S.Cancer stem cells in neuroblastoma therapy resistance.Cancer Drug Resist2019;2:948-67 PMCID:PMC6924637

[2] Aravindan N,Aravindan S.Emerging therapeutic targets for neuroblastoma.Expert Opin Ther Targets2020;24:899-914 PMCID:PMC7554151

[3] Sun SY,Lotan R.Apoptosis as a novel target for cancer chemoprevention.J Natl Cancer Inst2004;96:662-72

[4] Peinemann F,Enk H.Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.Cochrane Database Syst Rev2017;8:CD010685 PMCID:PMC6483698

[5] Reynolds CP,Villablanca JG.Retinoid therapy of high-risk neuroblastoma.Cancer Lett2003;197:185-92

[6] Bayeva N,Piskareva O.Differentiating neuroblastoma: a systematic review of the retinoic acid, its derivatives, and synergistic interactions.J Pers Med2021;11:211 PMCID:PMC7999600

[7] Redfern CP,Malcolm AJ.Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid.Eur J Cancer1995;31A:486-94

[8] Lima L,Marques D.Modulation of all-trans retinoic acid-induced MiRNA expression in neoplastic cell lines: a systematic review.BMC Cancer2019;19:866 PMCID:PMC6717326

[9] Yuza Y,Matsuzaki M,Urashima M.Gene and protein expression profiling during differentiation of neuroblastoma cells triggered by 13-cis retinoic acid.J Pediatr Hematol Oncol2003;25:715-20

[10] Finklestein JZ,Lenarsky C.13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.Med Pediatr Oncol1992;20:307-11

[11] Matthay KK.Is there a role for retinoids to treat minimal residual disease in neuroblastoma?.Br J Cancer2000;83:1121-3 PMCID:PMC2363592

[12] Ponzoni M,Chiesa V.Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.Cancer Re55:853-61

[13] Lovat PE,Corazzari M.Mechanisms of free-radical induction in relation to fenretinide-induced apoptosis of neuroblastoma.J Cell Biochem2003;89:698-708

[14] Maurer BJ,Seeger RC,Reynolds CP.Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.J Natl Cancer Inst1999;91:1138-46

[15] Raffaghello L,Pastorino F.In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.Int J Cancer2003;104:559-67

[16] Reynolds CP.Retinoid therapy of childhood cancer.Hematol Oncol Clin N Am2001;15:867-910

[17] Lovat PE,Goranov B,Redfern CP.Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells.Ann N Y Acad Sci2004;1028:81-9

[18] Lovat PE,Annichiarrico-Petruzzelli M.Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma.Exp Cell Res2000;260:50-60

[19] Cuperus R,Leen R.Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.Int J Oncol2008;32:1011-9

[20] Orienti I,Carosio R.Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumor drugs by complexation with amphiphilic dextrins.Drug Deliv2009;16:389-98

[21] Orienti I,Bergamante V.Fenretinide-polyvinylalcohol conjugates: new systems allowing fenretinide intravenous administration.Biomacromolecules2007;8:3258-62

[22] Di Paolo D,Zuccari G.Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.J Control Release2013;170:445-51

[23] Villablanca JG,Naranjo A.Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children’s Oncology Group.Clin Cancer Res2011;17:6858-66 PMCID:PMC3207022

[24] Maurer BJ,Villablanca JG.Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.Pediatr Blood Cancer2013;60:1801-8

[25] Villani MG,Cavadini E.4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.Cancer Res2006;66:3238-47

[26] Sogno I,Ferrari N.Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies.Crit Rev Oncol Hematol2010;75:2-14

[27] Ribatti D,Baronio M.Inhibition of neuroblastoma-induced angiogenesis by fenretinide.Int J Cancer2001;94:314-21

[28] Ribatti D,Marimpietri D.Fenretinide as an anti-angiogenic agent in neuroblastoma.Cancer Lett2003;197:181-4

[29] Bassiri H,Haber M,Norris MD.Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.Transl Pediatr2015;4:226-38 PMCID:PMC4729051

[30] Lozier AM,Grawe AP.Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma.Oncotarget2015;6:196-206 PMCID:PMC4381588

[31] Lewis EC,Ferguson W.A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.Int J Cancer2020;147:3152-9 PMCID:PMC7586843

[32] Sholler GLS,Bergendahl G.Maintenance DFMO Increases Survival in High Risk Neuroblastoma.Sci Rep2018;8:14445 PMCID:PMC6160434

[33] Ladumor Y,Hallett R.Vitamin D receptor activation attenuates hippo pathway effectors and cell survival in metastatic neuroblastoma.Mol Cancer Res2022;20:895-908 PMCID:PMC9177824

[34] Li S,Li S.Noscapine induced apoptosis via downregulation of survivin in human neuroblastoma cells having wild type or null p53.PLoS One2012;7:e40076

[35] Rizeq B,Ilesanmi J,Rahman MM.The power of phytochemicals combination in cancer chemoprevention.J Cancer2020;11:4521-33

[36] Akihisa T,Banno N.Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri.Biol Pharm Bull2006;29:1976-9

[37] Pacifico S,Lorenz P.Apolar Laurus nobilis leaf extracts induce cytotoxicity and apoptosis towards three nervous system cell lines.Food Chem Toxicol2013;62:628-37

[38] Aydın E,Keleş MS.The effect of carvacrol on healthy neurons and N2a cancer cells: some biochemical, anticancerogenicity and genotoxicity studies.Cytotechnology2014;66:149-57 PMCID:PMC3886536

[39] Hassannia B,Ingold I.Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma.J Clin Invest2018;128:3341-55 PMCID:PMC6063467

[40] Qu ZY,Zheng PH.New malonylginsenosides from the fresh fruits of Panax notoginseng.Fitoterapia2021;150:104844

[41] Poulose SM,Patil BS.Citrus limonoids induce apoptosis in human neuroblastoma cells and have radical scavenging activity.J Nutr2005;135:870-7

[42] Poulose SM,Patil BS.Antiproliferative effects of citrus limonoids against human neuroblastoma and colonic adenocarcinoma cells.Nutr Cancer2006;56:103-12

[43] Abate G,Pucci M.Phytochemical analysis and anti-inflammatory activity of different ethanolic phyto-extracts of artemisia annua L.Biomolecules2021;11:975 PMCID:PMC8301839

[44] Liu Y,Dong Q,Qiao L.Maslinic acid induces anticancer effects in human neuroblastoma cells mediated via apoptosis induction and caspase activation, inhibition of cell migration and invasion and targeting MAPK/ERK signaling pathway.AMB Express2020;10:104 PMCID:PMC7266924

[45] Yanagihara N,Toyohira Y.New insights into the pharmacological potential of plant flavonoids in the catecholamine system.J Pharmacol Sci2014;124:123-8

[46] Akao Y,Ohguchi K,Nozawa Y.Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.Bioorg Med Chem2008;16:2803-10

[47] Singhal SS,Singhal P,Horne D.Didymin: an orally active citrus flavonoid for targeting neuroblastoma.Oncotarget2017;8:29428-41 PMCID:PMC5438742

[48] Navarra M,Ferlazzo N,Schumacher U.Effect of citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models.Fitoterapia2014;95:83-92

[49] Alshangiti AM,Hegarty SV,O’Keeffe GW.The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells.Neuronal Signal2019;3:NS20180201 PMCID:PMC7104307

[50] Russo M,Daglia M.Understanding genistein in cancer: The “good” and the “bad” effects: A review.Food Chem2016;196:589-600

[51] Varshney M,Rana VS.An overview on therapeutic and medicinal potential of poly-hydroxy flavone viz. Heptamethoxyflavone, Kaempferitrin, Vitexin and Amentoflavone for management of Alzheimer’s and Parkinson’s diseases: a critical analysis on mechanistic insight.Crit Rev Food Sci Nutr2021;1-24

[52] Ge W,Xian H.Wogonin induced mitochondrial dysfunction and endoplasmic reticulum stress in human malignant neuroblastoma cells via IRE1α-dependent pathway.J Mol Neurosci2015;56:652-62

[53] Chen YH,Lo HC,Hseu YC.Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cells.Oncol Rep2012;27:1233-7 PMCID:PMC3583478

[54] Orlikova B,Golais F,Diederich M.Dietary chalcones with chemopreventive and chemotherapeutic potential.Genes Nutr2011;6:125-47 PMCID:PMC3092904

[55] Motani K,Kimura Y.Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma.Biol Pharm Bull2008;31:618-26

[56] Nishimura R,Arakawa M.Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma.Biol Pharm Bull2007;30:1878-83

[57] Chen Y,Lai HS.Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice.Surgery2004;136:57-66

[58] Liontas A.Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma.Anticancer Res2004;24:987-98.

[59] Aravindan S,Herman TS,Aravindan N.Molecular basis of “hypoxic” breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling.Radiat Oncol2013;8:46 PMCID:PMC3599951

[60] Melzig MF.Induction of neutral endopeptidase and angiotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol.Pharmazie2002;57:556-8.

[61] Huang FJ,Chan WH.Characterization of apoptosis induced by emodin and related regulatory mechanisms in human neuroblastoma cells.Int J Mol Sci2013;14:20139-56 PMCID:PMC3821607

[62] Morandi F,Calarco E.The olive leaves extract has anti-tumor effects against neuroblastoma through inhibition of cell proliferation and induction of apoptosis.Nutrients2021;13:2178 PMCID:PMC8308225

[63] Piletz JE,Roy D.Transepithelial anti-neuroblastoma response to kale among four vegetable juices using in vitro model co-culture system.Nutrients2021;13:488 PMCID:PMC7913023

[64] Horwacik I,Durbas M.Inhibition of autophagy by 3-methyladenine potentiates sulforaphane-induced cell death of BE₂-C human neuroblastoma cells.Mol Med Rep2015;12:535-42

[65] Hsu YC,Wang MY,Huang TY.Growth inhibition and apoptosis of neuroblastoma cells through ROS-independent MEK/ERK activation by sulforaphane.Cell Biochem Biophys2013;66:765-74

[66] Zhao P,Lee JY.Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.Invest New Drugs2018;36:743-54

[67] Cirmi S,Gugliandolo A.Moringin from moringa oleifera seeds inhibits growth, arrests cell-cycle, and induces apoptosis of SH-SY5Y human neuroblastoma cells through the modulation of nf-κb and apoptotic related factors.Int J Mol Sci2019;20:1930 PMCID:PMC6515259

[68] Ahmad B,Shah NA.Investigation of chemopreventive and antiproliferative potential of dicliptera roxburghiana.Integr Cancer Ther2022;21:15347354211069934 PMCID:PMC8753230

[69] Prasad R.Honokiol, an active compound of magnolia plant, inhibits growth, and progression of cancers of different organs.Adv Exp Med Biol2016;928:245-65

[70] Lin JW,Hong CY.Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway.Neuro Oncol2012;14:302-14 PMCID:PMC3280802

[71] Yeh PS,Chang YA,Wang JJ.Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.Cancer Lett2016;370:66-77

[72] Lv X,Shang Y.Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.Oncol Rep2015;34:1289-300

[73] Baldassarre F,De Castro F.Enhanced bioactivity of pomegranate peel extract following controlled release from CaCO₃ nanocrystals.Bioinorg Chem Appl2022;2022:6341298 PMCID:PMC8858070

[74] Okuzumi J,Murakoshi M.Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells.Cancer Lett1990;55:75-81

[75] Wang SK,White WL.Extracts from New Zealand Undaria pinnatifida containing fucoxanthin as potential functional biomaterials against cancer in vitro.J Funct Biomater2014;5:29-42 PMCID:PMC4099972

[76] Liao X.Tryptanthrin induces growth inhibition and neuronal differentiation in the human neuroblastoma LA-N-1 cells.Chem Biol Interact2013;203:512-21

[77] Liao X,Mak NK.Tryptanthrin inhibits angiogenesis by targeting the VEGFR2-mediated ERK1/2 signalling pathway.PLoS One2013;8:e82294 PMCID:PMC3864955

[78] Muthukumar V.Molecular interaction of Survivin and Piperine by computational docking analyses for neuroblastoma targeting.Ann Neurosci2011;18:145-7 PMCID:PMC4116959

[79] Yun YS,Takahashi S,Inoue H.Piperine-like alkamides from Piper nigrum induce BDNF promoter and promote neurite outgrowth in Neuro-2a cells.J Nat Med2018;72:238-45

[80] Ouhtit A,Abdraboh M.Simultaneous inhibition of cell-cycle, proliferation, survival, metastatic pathways and induction of apoptosis in breast cancer cells by a phytochemical super-cocktail: genes that underpin its mode of action.J Cancer2013;4:703-15 PMCID:PMC3842439